AimsWe investigated whether the deterioration in asthma control reported following cessation of theophylline was due to tolerance to theophylline. Methods Eighteen subjects with mild stable asthma were given oral theophylline 10 mg kg −1 day −1 or placebo for 2 weeks in a double-blind crossover study. FEV 1 and PD 20 histamine were measured before and 8 h after the first dose of treatment and 8, 32 and 56 h after the final dose. PD 20 AMP was measured before treatment and 9 h after the final dose.Results Six patients did not tolerate theophylline. In the other 12 subjects there were no differences between treatments in daily PEF, symptom scores, rescue bronchodilator use, PD 20 histamine or FEV 1 up to 8 h post treatment. Following withdrawal of theophylline there were significantly lower values for mean FEV 1 (mean difference 0.15 l, 95% CI 0.03, 026) and PD 20 AMP compared to placebo but no difference in other end points.Conclusions The small rebound deterioration in lung function following regular treatment with therapeutic doses of oral theophylline is consistent with the development of tolerance.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.